Clin2
NCT06858644Possibly a fitNot yet recruiting

Predicting stomach cancer spread and weight loss from imaging and tissue

Gastric (Stomach) Cancer

Part of Cancer, Digestive system clinical trials.

This study uses your existing CT/MRI images and biopsy tissue to build a computer model that may help predict if your stomach cancer will spread to the abdomen or cause weight loss. You won't receive a new treatment, but your data could improve future care for stomach cancer patients.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
500 people
Ages
18 years to 75 years
Study type
Observational

Who can take part

  • You are between 18 and 75 years old.
  • You have been diagnosed with stomach cancer (at any stage) and it has been confirmed by a biopsy.
  • You have CT or MRI scans of your tumor available for review.
  • You are at risk of or have cancer spread to the lining of the abdomen (peritoneal metastasis) or cancer-related weight loss (cachexia).
  • You do not have other primary cancers or serious health conditions like severe heart disease or uncontrolled diabetes.
  • You are not pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07776067Recruiting
CT scans to predict outcomes in gastric cancer

This study looks at CT scans and clinical information from people with stomach cancer to see if they can help predict how the disease will progress. It may help doctors better understand each patient's situation.

Wuhan, Hubei
NCT06947096Enrolling by invitation
AI prediction of stomach cancer spread to lymph nodes

This study uses artificial intelligence to analyze your CT scan and predict whether stomach cancer has spread to lymph nodes behind your belly. The goal is to help doctors decide if you need more extensive surgery.

Shijiazhuang, None Selected
NCT07697079Not yet recruiting
Predicting stomach cancer response to chemotherapy using scans and blood tests

This trial uses advanced imaging (ultrasound and CT) plus a blood test to predict how well your stomach cancer will respond to chemotherapy given before surgery. The goal is to personalize your treatment and improve outcomes.

Jinan, Shandong
NCT07124754Recruiting
Predicting lymph node spread in early stomach cancer

This study tests if artificial intelligence can predict whether early-stage stomach cancer has spread to lymph nodes. It also evaluates how well doctors assess the cancer. If the technology works, it could help guide treatment decisions.

Shijiazhuang, None Selected
NCT05722275Recruiting
Predicting peritoneal spread in advanced stomach cancer

This trial uses CT scan images and a look inside the abdomen (laparoscopy) to predict whether advanced stomach cancer has spread to the lining of the abdomen (the peritoneum). It may help your care team better identify who already has peritoneal spread and who might not.

Beijing
NCT07683195Enrolling by invitation
Using CT scans to predict early stomach cancer return

This study uses information from CT scans done before stomach cancer surgery to see if it can predict whether the cancer may come back early. Researchers want to find patterns in the scans that might help doctors plan better follow-up care.

Jinan, Shandong

Hear when a new Gastric (Stomach) Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.